All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0712 | Human anti-MRM1 T cell receptor (AB5), pCDTCR1 | Human | AB5 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0713 | Human anti-MRM1 T cell receptor (BA5), pCDTCR1 | Human | BA5 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0714 | Human anti-MRM1 T cell receptor (BE7), pCDTCR1 | Human | BE7 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0715 | Human anti-MRM1 T cell receptor (BG1), pCDTCR1 | Human | BG1 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0716 | Human anti-MRM1 T cell receptor (I4), pCDTCR1 | Human | I4 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0717 | Human anti-MRM1 T cell receptor (J20), pCDTCR1 | Human | J20 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0718 | Human anti-MRM1 T cell receptor (K7), pCDTCR1 | Human | K7 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0719 | Human anti-MRM1 T cell receptor (MG8), pCDTCR1 | Human | MG8 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0720 | Human anti-MRM1 T cell receptor (N5), pCDTCR1 | Human | N5 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector | |
TCR-YC0721 | Human anti-MRM1 T cell receptor (N9), pCDTCR1 | Human | N9 | Human | LLFGMTPCL | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION